Zobrazeno 1 - 9
of 9
pro vyhledávání: '"A Bernalte-Sesé"'
Autor:
Rubio-Gomis, E., Martinez-Mir, I., Morales-Olivas, F.J., Martorell-Aragones, A., Palop-Larrea, V., Bernalte-Sesé, A., Cerda-Mir, J.C., Polo-Martín, P., Febrer, I., Aranda-Grau, L., Llosa-Cortes, I., Tejedor-Sanz, Mª.J., Julia-Benito, J.C., Alvarez-de-Laviada-Mulero, T., Planelles-Cantarino, Mª.V., Apolinar-Valiente, E., Loriente-Tur, M., Abella-Bazataqui, A.M., Alvarez-Gonzalez, I., Morales-Carpi, C., Burches-Greus, Mª.E., Ferrer-Bautista, A.B., Felix-Toledo, R., Marmaneu-Laguia, D., Garcia-Martinez, V.E., Beltran-Marques, Mª.A., Rodriguez-Gracia, B.
Publikováno v:
In Allergologia et Immunopathologia July-August 2018 46(4):378-384
Autor:
MP Ortega-Garcia, I Toledo-Guasp, R Laguía-Sánchez, R Fuster-Talens, C Pedrós-Cholvi, A Bernalte-Sesé, P Blasco-Segura
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e34ec2f7b0b2e429cda732a3aad3ed46
https://doi.org/10.1136/ejhpharm-2022-eahp.200
https://doi.org/10.1136/ejhpharm-2022-eahp.200
Autor:
F. Sanz-Herrero, F. Puchades-Gimeno, P Blasco-Segura, A. Moya-Gil, A Bernalte-Sesé, M. Garcia-Deltoro, C. Ferrer-Gómez, MP Ortega-García, I Gil-Gómez
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Anakinra is a recombinant interleukin 1 (IL-1) receptor antagonist and might help to neutralise the acute respiratory distress syndrome (ARDS) related to the SARS-CoV-2 hyperinflammatory state. Aim and objectives To evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a66caa97ae193a578f6276440638bc73
https://doi.org/10.1136/ejhpharm-2021-eahpconf.153
https://doi.org/10.1136/ejhpharm-2021-eahpconf.153
Autor:
I. Llosa-Cortes, I. Alvarez-Gonzalez, A. Martorell-Aragones, Mª.V. Planelles-Cantarino, V.E. Garcia-Martinez, A.M. Abella-Bazataqui, R. Felix-Toledo, J.C. Julia-Benito, E. Apolinar-Valiente, A. Bernalte-Sesé, Mª.A. Beltran-Marques, E. Rubio-Gomis, A.B. Ferrer-Bautista, L. Aranda-Grau, B. Rodriguez-Gracia, T. Alvarez-de-Laviada-Mulero, Mª.J. Tejedor-Sanz, C. Morales-Carpi, V. Palop-Larrea, D. Marmaneu-Laguia, M. Loriente-Tur, Francisco J. Morales-Olivas, I. Febrer, Mª.E. Burches-Greus, J. C. Cerdá-Mir, P. Polo-Martín, I. Martinez-Mir
Publikováno v:
ALLERGOLOGIA ET IMMUNOPATHOLOGIA
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Allergologia Et Immunopathologia
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Allergologia Et Immunopathologia
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Background: The long-term efficacy of corticosteroids to prevent atopic dermatitis (AD) relapses has partially been addressed in children. This study compared an intermittent dosing regimen of fluticasone propionate (FP) cream 0.05% with its vehicle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ae6fa9bf1f44542549108ac93095b18
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3922
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3922
Publikováno v:
Farmacia Hospitalaria, Volume: 41, Issue: 5, Pages: 651-653, Published: OCT 2017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______624::ac3975dbe9db0dcddf507b359bc65319
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000500651&lng=en&tlng=en
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000500651&lng=en&tlng=en
Autor:
Bernalte Sesé, Javier
Publikováno v:
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
instname
Proyecto confidencial (Riunet)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1fdaf45e9c404e03271bdeeedd1322da
http://hdl.handle.net/10251/44001
http://hdl.handle.net/10251/44001
Autor:
P Blasco-Segura, MP Ortega-García, FJ López-Pérez, A Bernalte-Sesé, J Cortijo-Jimeno, J Milara-Payá, M García-López, E Ortega-González, M Diago
Publikováno v:
European Journal of Hospital Pharmacy. 21:A26.2-A27
Background Hepatitis C virus genotype 1a (HCV-1a) is a predictor of poor response to peginterferon-ribavirin treatment, which has been associated with a lower resistance barrier, compared to HCV genotype 1b (HCV-1b). Variations in the human IL28B gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2abbaef2ca79571f6a5f674e3b65ff3
https://doi.org/10.1136/ejhpharm-2013-000436.64
https://doi.org/10.1136/ejhpharm-2013-000436.64
Autor:
M Diago, FJ López-Pérez, J Milara-Payá, A Bernalte-Sesé, M García-López, E Ortega-González, J Cortijo-Gimeno, P Blasco-Segura, MP Ortega-García
Publikováno v:
European Journal of Hospital Pharmacy. 21:A27.1-A27
Background Interleukin-28B genetic polymorphism is a key predictor of response to peginterferon-ribavirin treatment in hepatitis C virus (HCV) genotype 1 infection (HCVg1i), CC interleukin-28B genotype (IL28Bg) being highly predictive of efficacy. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::245847ab711c37e064aa30a3cfddc8ca
https://doi.org/10.1136/ejhpharm-2013-000436.65
https://doi.org/10.1136/ejhpharm-2013-000436.65
Autor:
Elena Rubio, Inocencia Martinez-Mir, Francisco J Morales-Olivas, Antonio Martorell-Aragonés, Vicente Palop Larrea, Alejandro Bernalte Sesé, Juan C Cerdá Mir, Pedro Polo Martín, Isabel Febrer, Laura Aranda Grau, Inmaculada Llosa Cortes, María José Tejedor Sanz, Juan C Juliá Benito, Teresa Álvarez De Laviada, María Victoria Planelles Cantarino, Esther Apolinar Valiente, Mercedes Loriente Tur, Antonio M Abella Bazataqui, Irene Álvarez Gonzalez, Cristina Morales-Carpi, Maria Enrriqueta Burches Greu, Ana B Ferrer Bautista, Raúl Felix Toledo, Dolores Marmeneu Laguia, Victoria E Garcia-Martinez, María Antonia Beltran Marques, María Begoña Rodriguez Gracia
Publikováno v:
The World Allergy Organization Journal
Allergic diseases of the skin and drug allergies – 2015. Randomized controlled, double blind trial of topical twice weekly fluticasone propionate maintenance treatment to reduce risk of relapse in mild or moderate atopic dermatitis in children Elen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a9127c0971f2353a2c5d6d3d1be28d
http://europepmc.org/articles/PMC3643560
http://europepmc.org/articles/PMC3643560